Financial statements Beta Bio Technology
Balance sheet of Beta Bio Technology
Company age:
Age:
11 y. 10 m. 3 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BETA BIO TECHNOLOGY
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 1 540 846,61 | 1 238 922,14 | 2 313 645,37 | 1 643 187,62 |
| A. Fixed assets | 674 291,88 | 654 021,06 | 8 888,62 | 1 743,67 |
| B. Current assets | 866 554,73 | 584 901,08 | 2 144 756,75 | 1 641 443,95 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 160 000,00 | 0,00 |
| Total liabilities | 1 540 846,61 | 1 238 922,14 | 2 313 645,37 | 1 643 187,62 |
| A. Equity | 977 136,49 | 521 224,07 | 1 582 162,48 | 1 529 525,11 |
| B. Liabilities and provisions for liabilities | 563 710,12 | 717 698,07 | 731 482,89 | 113 662,51 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.